Literature DB >> 32618281

COVID-19 on the African continent.

Chad R Wells1, Jason K Stearns2, Pascal Lutumba3, Alison P Galvani4.   

Abstract

Entities:  

Year:  2020        PMID: 32618281      PMCID: PMC7202849          DOI: 10.1016/S1473-3099(20)30374-1

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


× No keyword cloud information.
As of April 20, 2020, 14 068 people have been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Africa, of whom 3158 (22·4%) are in South Africa. The transmissibility of SARS-CoV-2, combined with the scarcity of crucial health equipment and the challenges of implementing widespread physical distancing and case isolation, poses a grave threat to the continent. To illustrate the potential burden of SARS-CoV-2 epidemics within the most vulnerable countries in Africa, we simulated a SARS-CoV-2 outbreak in DR Congo in the absence of interventions. Using an age-structured epidemiological model (appendix p 1), and assuming a basic reproductive number of 2·72 (95% CI 2·56–2·87), we estimate that there would be 76 213 155 infections (95% CI 74 156 965–77 800 029) and 319 441 deaths (313 079–324 175) in the absence of physical distancing (figure ). Although individuals younger than 20 years account for 42 752 770 (95% CI 41 551 696–43 683 014; 56·1%) of these simulated SARS-CoV-2 infections, individuals aged 50 years and older constitute 280 623 (275 356–284 509; 87·8%) of the deaths in our model prediction. Given the high prevalence of comorbidities in DR Congo, as there is in Africa more broadly, the death toll could even be much higher.
Figure

Projected burden of COVID-19 in DR Congo in the absence of any control measures for a range of basic reproductive numbers

The total number of COVID-19 cases (A) and deaths (B) estimated for basic reproductive numbers between 1·2 and 2·9. Details on how we calculated the basic reproductive numbers can be found in the appendix (p 1). COVID-19=coronavirus disease 2019.

Projected burden of COVID-19 in DR Congo in the absence of any control measures for a range of basic reproductive numbers The total number of COVID-19 cases (A) and deaths (B) estimated for basic reproductive numbers between 1·2 and 2·9. Details on how we calculated the basic reproductive numbers can be found in the appendix (p 1). COVID-19=coronavirus disease 2019. Sparse testing capacity makes assessing the true burden of coronavirus disease 2019 (COVID-19) and implementing effective case isolation difficult. For example, by mid-April 2020, DR Congo was only doing around 200 tests per day, Senegal around 300 tests per day, and Ethiopia around 400 tests per day. In addition, there are scarce resources for treating critically ill patients with COVID-19. Compared with the USA, a country with more than 120 000 ventilators, there are fewer than 2000 ventilators spread across 41 African countries, only five of which are in DR Congo.6, 7 Physical distancing and other control measures have been implemented in some parts of African countries, including in the capital of DR Congo. However, authorities in Ghana and South Africa have already begun to consider lifting restrictions. Given the dearth of health-care facilities and equipment across Africa, we urge investing heavily in prevention, including lockdowns focused on densely populated areas and shelter-in-place orders for the most vulnerable. Simultaneously, the socioeconomic considerations of the population and the disparate local realities of the 54 African countries must be taken into account. Mitigation strategies must be implemented in conjunction with social protection measures, such as price controls, the waving of utility bills and taxes, and targeted cash transfers. A concerted international effort is both moral and pragmatic for achieving this goal. However, on April 14, 2020, the US President announced that the USA will suspend its funding of WHO. Such action would be shortsighted, imperilling the containment of SARS-CoV-2. Protecting Africa is essential, not only for the continent itself, but also to safeguard the rest of the world. Given the potential for SARS-CoV-2 to reseed, even as some countries extinguish their current epidemics, the worldwide population is only as safe as its most vulnerable nations.
  7 in total

1.  Epidemiological, virological and clinical features of SARS-CoV-2 among individuals during the first wave in Cameroon: Baseline analysis for the EDCTP PERFECT-Study RIA2020EF-3000.

Authors:  Joseph Fokam; Désiré Takou; Alex Durand Nka; Aude Christelle Ka'e; Bouba Yagai; Collins Ambe Chenwi; Ezechiel Ngoufack Jagni Semengue; Grâce Angong Beloumou; Sandrine Claire Djupsa Ndjeyep; Aissatou Abba; Willy Pabo; Davy Gouissi; Michel Carlos Tommo Tchouaket; Laeticia Yatchou; Krystel Zam; Lucien Mama; Regine Claudette Ekitti; Nadine Fainguem; Rachel Kamgaing; Samuel Martin Sosso; Nicaise Ndembi; Vittorio Colizzi; Carlo-Federico Perno; Alexis Ndjolo
Journal:  J Public Health Afr       Date:  2022-05-24

2.  An Observational Laboratory-Based Assessment of SARS-CoV-2 Molecular Diagnostics in Benin, Western Africa.

Authors:  Anna-Lena Sander; Anges Yadouleton; Andres Moreira-Soto; Christian Drosten; Carine Tchibozo; Gildas Hounkanrin; Yvette Badou; Carlo Fischer; Nina Krause; Petas Akogbeto; Edmilson F de Oliveira Filho; Anges Dossou; Sebastian Brünink; Melchior A Joël Aïssi; Mamoudou Harouna Djingarey; Benjamin Hounkpatin; Michael Nagel; Jan Felix Drexler
Journal:  mSphere       Date:  2021-01-13       Impact factor: 4.389

3.  Wastewater-based epidemiology in hazard forecasting and early-warning systems for global health risks.

Authors:  B Kasprzyk-Hordern; B Adams; I D Adewale; F O Agunbiade; M I Akinyemi; E Archer; F A Badru; J Barnett; I J Bishop; M Di Lorenzo; P Estrela; J Faraway; M J Fasona; S A Fayomi; E J Feil; L J Hyatt; A T Irewale; T Kjeldsen; A K S Lasisi; S Loiselle; T M Louw; B Metcalfe; S A Nmormah; T O Oluseyi; T R Smith; M C Snyman; T O Sogbanmu; D Stanton-Fraser; S Surujlal-Naicker; P R Wilson; G Wolfaardt; C O Yinka-Banjo
Journal:  Environ Int       Date:  2022-02-14       Impact factor: 9.621

4.  The early SARS-CoV-2 epidemic in Senegal was driven by the local emergence of B.1.416 and the introduction of B.1.1.420 from Europe.

Authors:  Lester J Perez; Gregory S Orf; Michael G Berg; Mary A Rodgers; Todd V Meyer; Aurash Mohaimani; Ana Olivo; Barbara Harris; Illya Mowerman; Abdou Padane; Agbogbenkou Tevi Dela-Del Lawson; Aminata Mboup; Moustapha Mbow; Nafissatou Leye; Ndeye Coumba Touré-Kane; Ambroise D Ahouidi; Gavin A Cloherty; Souleymane Mboup
Journal:  Virus Evol       Date:  2022-03-21

5.  SARS-CoV-2 epidemic in African countries-are we losing perspective?

Authors:  Andreas Kalk; Andreas Schultz
Journal:  Lancet Infect Dis       Date:  2020-08-07       Impact factor: 25.071

6.  Humanitarian Surgical Missions in Times of COVID-19: Recommendations to Safely Return to a Sub-Saharan Africa Low-Resource Setting.

Authors:  Víctor Lopez-Lopez; Ana Morales; Elisa García-Vazquez; Miguel González; Quiteria Hernandez; Alberto Baroja-Mazo; Dolores Palazon; Jose A Tortosa; Maria A Rodriguez; Nuria M Torregrosa; Winnie Kanyi; J K Ndungu; José Gil Martinez; José M Rodriguez
Journal:  World J Surg       Date:  2021-02-20       Impact factor: 3.282

7.  High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.

Authors:  Antoine N Nkuba; Sheila M Makiala; Emilande Guichet; Paul M Tshiminyi; Yannick M Bazitama; Marc K Yambayamba; Benito M Kazenza; Trésor M Kabeya; Elysee B Matungulu; Lionel K Baketana; Naomi M Mitongo; Guillaume Thaurignac; Fabian H Leendertz; Veerle Vanlerberghe; Raphaël Pelloquin; Jean-François Etard; David Maman; Placide K Mbala; Ahidjo Ayouba; Martine Peeters; Jean-Jacques T Muyembe; Eric Delaporte; Steve M Ahuka
Journal:  Clin Infect Dis       Date:  2022-03-09       Impact factor: 9.079

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.